AAAAAA
Results:
1-23
|
Results: 23
Authors:
Eisele, F
Kuhlmann, J
Waldmann, H
Citation: F. Eisele et al., Synthesis and membrane-binding properties of a characteristic lipopeptide from the membrane-anchoring domain of influenza virus A hemagglutinin, ANGEW CHEM, 40(2), 2001, pp. 369-373
Authors:
Kuhlmann, J
Herrmann, C
Citation: J. Kuhlmann et C. Herrmann, Biophysical characterization of the Ras protein, T CURR CHEM, 211, 2001, pp. 61-116
Authors:
Kuhlmann, J
Muck, W
Citation: J. Kuhlmann et W. Muck, Clinical-pharmacological strategies to assess drug interaction potential during drug development, DRUG SAFETY, 24(10), 2001, pp. 715-725
Authors:
Renault, L
Kuhlmann, J
Henkel, A
Wittinghofer, A
Citation: L. Renault et al., Structural basis for guanine nucleotide exchange on Ran by the regulator of chromosome condensation (RCC1), CELL, 105(2), 2001, pp. 245-255
Authors:
Bose, G
Kuhlmann, J
Plass, M
Muller, O
Citation: G. Bose et al., Microplate enzyme-linked immunosorbent assay for the detection of primary DNA alterations based on the interaction with UvrA/UvrB, ANALYT BIOC, 292(1), 2001, pp. 1-7
Authors:
Kuhn, K
Owen, DJ
Bader, B
Wittinghofer, A
Kuhlmann, J
Waldmann, H
Citation: K. Kuhn et al., Synthesis of functional Ras lipoproteins and fluorescent derivatives, J AM CHEM S, 123(6), 2001, pp. 1023-1035
Authors:
Kadereit, D
Kuhlmann, J
Waldmann, H
Citation: D. Kadereit et al., Linking the fields - The interplay of organic synthesis, biophysical chemistry, and cell biology in the chemical biology of protein lipidation, CHEMBIOCHEM, 1(3), 2000, pp. 144-169
Authors:
Erdmann, KS
Kuhlmann, J
Lessmann, V
Herrmann, L
Eulenburg, V
Muller, O
Heumann, R
Citation: Ks. Erdmann et al., The Adenomatous Polyposis Coli-protein (APC) interacts with the protein tyrosine phosphatase PTP-BL via an alternatively spliced PDZ domain, ONCOGENE, 19(34), 2000, pp. 3894-3901
Authors:
Kuhlmann, J
Citation: J. Kuhlmann, Tasks of clinical pharmacology in the early phase of drug development, MED KLIN, 95, 2000, pp. 31-40
Authors:
Ahr, G
Voith, B
Kuhlmann, J
Citation: G. Ahr et al., Guidances related to bioavailability and bioequivalence: European industryperspective, EUR J DRUG, 25(1), 2000, pp. 25-27
Authors:
Bader, B
Kuhn, K
Owen, DJ
Waldmann, H
Wittinghofer, A
Kuhlmann, J
Citation: B. Bader et al., Bioorganic synthesis of lipid-modified proteins for the study of signal transduction, NATURE, 403(6766), 2000, pp. 223-226
Authors:
Chaillan-Huntington, C
Braslavsky, CV
Kuhlmann, J
Stewart, M
Citation: C. Chaillan-huntington et al., Dissecting the interactions between NTF2, RanGDP, and the nucleoporin XFXFG repeats, J BIOL CHEM, 275(8), 2000, pp. 5874-5879
Authors:
Braslavsky, CIV
Nowak, C
Gorlich, D
Wittinghofer, A
Kuhlmann, J
Citation: Civ. Braslavsky et al., Different structural and kinetic requirements for the interaction of Ran with the Ran-binding domains from RanBP2 and importin-beta, BIOCHEM, 39(38), 2000, pp. 11629-11639
Authors:
Schelhaas, M
Nagele, E
Kuder, N
Bader, B
Kuhlmann, J
Wittinghofer, A
Waldmann, H
Citation: M. Schelhaas et al., Chemoenzymatic synthesis of biotinylated Ras peptides and their use in membrane binding studies of lipidated model proteins by surface plasmon resonance, CHEM-EUR J, 5(4), 1999, pp. 1239-1252
Authors:
Cotte, A
Bader, B
Kuhlmann, J
Waldmann, H
Citation: A. Cotte et al., Synthesis of the N-terminal lipohexapeptide of human G(alpha o)-protein and fluorescent-labeled analogues for biological studies, CHEM-EUR J, 5(3), 1999, pp. 922-936
Authors:
Kuhlmann, J
Citation: J. Kuhlmann, Alternative strategies in drug development: clinical pharmacological aspects, INT J CL PH, 37(12), 1999, pp. 575-583
Authors:
Schlupen, J
Haegel, FH
Kuhlmann, J
Geisler, H
Schwuger, MJ
Citation: J. Schlupen et al., Sorption hysteresis of pyrene on zeolite, COLL SURF A, 156(1-3), 1999, pp. 335-347
Authors:
Kuhlmann, J
Citation: J. Kuhlmann, Tasks of clinical pharmacology in the early phase of drug development, MED KLIN, 94(5), 1999, pp. 290-299
Authors:
Kuhlmann, J
Berger, W
Podzuweit, H
Schmidt, U
Citation: J. Kuhlmann et al., The influence of valerian treatment on "Reaction time, alertness and concentration" in volunteers, PHARMACOPS, 32(6), 1999, pp. 235-241
Authors:
Vormfelde, SV
Muck, W
Freudenthaler, SM
Heyen, P
Schmage, N
Kuhlmann, J
Muller, GA
Gundert-Remy, UM
Gleiter, CH
Citation: Sv. Vormfelde et al., Pharmacokinetics of cerivastatin in renal impairment are predicted by low serum albumin concentration rather than by low creatinine clearance, J CLIN PHAR, 39(2), 1999, pp. 147-154
Authors:
Vetter, IR
Nowak, C
Nishimoto, T
Kuhlmann, J
Wittinghofer, A
Citation: Ir. Vetter et al., Structure of a Ran-binding domain complexed with Ran bound to a GTP analogue: implications for nuclear transport, NATURE, 398(6722), 1999, pp. 39-46
Authors:
Muck, W
Mai, I
Fritsche, L
Ochmann, K
Rohde, G
Unger, S
Johne, A
Bauer, S
Budde, K
Roots, I
Neumayer, HH
Kuhlmann, J
Citation: W. Muck et al., Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients, CLIN PHARM, 65(3), 1999, pp. 251-261
Authors:
Geyer, M
Assheuer, R
Klebe, C
Kuhlmann, J
Becker, J
Wittinghofer, A
Kalbitzer, HR
Citation: M. Geyer et al., Conformational states of the nuclear GTP-binding protein Ran and its complexes with the exchange factor RCC1 and the effector protein RanBP1, BIOCHEM, 38(35), 1999, pp. 11250-11260
Risultati:
1-23
|